Skip to main content

Zentek Ltd(ZEN-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low1.360
Day High1.440
Open:1.380
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Newsfile
Zentek's ZenGUARD(TM) Enhanced Air Filters Now Available for Direct Procurement by All Federal Departments and Agencies
Newsfile
Zentek Accepting Canadian Commercial Orders for ZenGUARD(TM) Enhanced Air Filters Following Health Canada Regulatory Classification
Newsfile
Albany Graphite Launches Year Two Environmental and Social Baseline Program with ERM and Constance Lake First Nation
Newsfile
Zentek Ltée : Albany Graphite Corp. mandate AppEco pour une étude indépendante de recherche de marché et d'analyse économique
Newsfile
Albany Graphite Executes Agreement with AETC for Certified Samples and Process Engineering, Completing the Set of Three Independent Workstreams Feeding the PEA
Newsfile
Albany Graphite Corp. Engages AppEco for Independent Market Research and Economic Analysis
Newsfile
Triera Biosciences Completes Innovative Solutions Canada Contract, Advances Platform Toward New Candidate Development
Newsfile
Albany Graphite Corp. Engages Micon International to Complete New PEA for Albany Graphite Project
Newsfile
Zentek Engages ICP Securities Inc. for Automated Market Making Services
ACCESS Newswire
Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification
ACCESS Newswire
Zentek Ltd. Receives Favorable Judgment in Long-Standing Litigation
ACCESS Newswire
Zentek Provides PDAC 2026 Update - Government and First Nations Engagement
ACCESS Newswire
Zentek Announces Pilot Evaluation Program with Quality Filters Inc.
ACCESS Newswire
Zentek Outlines Government Engagement Strategy and Announces Plans to Advance Albany Graphite Toward New Preliminary Economic Assessment
ACCESS Newswire
Zentek Ltd. Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement
ACCESS Newswire
Zentek Provides Strategic and Regulatory Update
Newsfile
Zentek Issues Shareholder Letter Outlining Strategic Reset and Focused Growth Plan
ACCESS Newswire
Zentek's Albany Graphite Has Demonstrated Nuclear Grade Performance in Independent Testing, Opening Pathways Into a Range of High-Return Commercial Markets
ACCESS Newswire
Zentek Subsidiary Albany Graphite Corp. Achieves Near-Theoretical Anode Performance in Battery Suitability Independent Testing

Profile

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.